Global Patent Index - EP 1003842 A1

EP 1003842 A1 20000531 - CATALYTIC MONOCLONAL ANTIBODIES FOR THE IN VIVO TRANSFORMATION OF CORTICOSTEROID PRODRUGS

Title (en)

CATALYTIC MONOCLONAL ANTIBODIES FOR THE IN VIVO TRANSFORMATION OF CORTICOSTEROID PRODRUGS

Title (de)

KATALITISCHE MONOKLONALE ANTIKÖRPER FÜR IN-VIVO TRANSFORMAZION VON CORICOSTEROID-ARZTNEIMITTELN VORSTUFE

Title (fr)

ANTICORPS MONOCLONAUX CATALYTIQUES SERVANT A LA TRANSFORMATION IN VIVO DE BIOPRECURSEURS DE CORTICOSTEROIDES

Publication

EP 1003842 A1 20000531 (EN)

Application

EP 98938707 A 19980727

Priority

  • EP 9804682 W 19980727
  • IT MI971825 A 19970730

Abstract (en)

[origin: WO9906536A1] Catalytic monoclonal antibodies (abzymes) for the in vivo transformation of corticosteroid prodrugs ae herein disclosed. These abzymes are advantageously used in emergency therapy of acute adrenal insufficiency allowing a prompt pharmacological action of the corticosteroid. Haptens against which the abzymes are generated are also disclosed.

IPC 1-7

C12N 9/00; C07J 51/00

IPC 8 full level

C07J 51/00 (2006.01); C07K 16/18 (2006.01); C12N 9/00 (2006.01); C12N 15/02 (2006.01); C12P 21/08 (2006.01); A61K 38/00 (2006.01)

CPC (source: EP)

A61P 5/38 (2017.12); C07J 51/00 (2013.01); C12N 9/0002 (2013.01); A61K 38/00 (2013.01)

Citation (search report)

See references of WO 9906536A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9906536 A1 19990211; AU 736187 B2 20010726; AU 8732898 A 19990222; CA 2299623 A1 19990211; CN 1268174 A 20000927; EP 1003842 A1 20000531; IT 1293510 B1 19990301; IT MI971825 A1 19990130; JP 2001512006 A 20010821; NO 20000395 D0 20000126; NO 20000395 L 20000328; NZ 502526 A 20020927

DOCDB simple family (application)

EP 9804682 W 19980727; AU 8732898 A 19980727; CA 2299623 A 19980727; CN 98808387 A 19980727; EP 98938707 A 19980727; IT MI971825 A 19970730; JP 2000505278 A 19980727; NO 20000395 A 20000126; NZ 50252698 A 19980727